The perceived effects of smoked cannabis
on patients with multiple sclerosis
by
Consroe P, Musty R, Rein J, Tillery W, Pertwee R.
Department of Pharmacology/Toxicology,
University of Arizona Health Sciences Center,
Tucson 85721-0207, USA.
consroe@pharmacy.arizona.edu
Eur Neurol 1997; 38(1):44-8
ABSTRACTFifty-three UK and 59 USA people with multiple sclerosis (MS) answered anonymously the first questionnaire on cannabis use and MS. From 97 to 30% of the subjects reported cannabis improved (in descending rank order): spasticity, chronic pain of extremities, acute paroxysmal phenomenon, tremor, emotional dysfunction, anorexia/weight loss, fatigue states, double vision, sexual dysfunction, bowel and bladder dysfunctions, vision dimness, dysfunctions of walking and balance, and memory loss. The MS subjects surveyed have specific therapeutic reasons for smoking cannabis. The survey findings will aid in the design of a clinical trial of cannabis or cannabinoid administration to MS patients or to other patients with similar signs or symptoms.Sativex
Anandamide
Cannabis: effects
Forgetful rodents
Stoned chocaholics?
The nectar of delight
Cannabis and schizophrenia
Cannabinoids/Parkinson's disease
Cannabinoids in multiple sclerosis model
Cannabis and cannabinoids for multiple sclerosis01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
Refs
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family
